233 related articles for article (PubMed ID: 9785332)
1. Anemia and quality of life in cancer patients: impact of transfusion and erythropoietin.
Thomas ML
Med Oncol; 1998 Aug; 15 Suppl 1():S13-8. PubMed ID: 9785332
[TBL] [Abstract][Full Text] [Related]
2. [General principles of treatment of anemia in cancer patients].
Spaeth D
Bull Cancer; 2002 Nov; 89(11):935-47. PubMed ID: 12495881
[TBL] [Abstract][Full Text] [Related]
3. The blue cross blue shield assessment technology review: summary of findings.
Bennett CL
Best Pract Res Clin Haematol; 2005; 18(3):423-31. PubMed ID: 15792916
[TBL] [Abstract][Full Text] [Related]
4. Quality of life: subjective and objective improvements with recombinant human erythropoietin therapy.
Lundin AP
Semin Nephrol; 1989 Mar; 9(1 Suppl 1):22-9. PubMed ID: 2648517
[TBL] [Abstract][Full Text] [Related]
5. Effects of cancer-related anemia on clinical and quality-of-life outcomes.
Gillespie TW
Clin J Oncol Nurs; 2002; 6(4):206-11. PubMed ID: 12087616
[TBL] [Abstract][Full Text] [Related]
6. Recombinant human erythropoietin treatment of anemic cancer patients.
Henry DH
Cancer Pract; 1996; 4(4):180-4. PubMed ID: 8900758
[TBL] [Abstract][Full Text] [Related]
7. Clinical application of recombinant erythropoietin in anemic cancer patients.
Henry DH
Hematol Oncol Clin North Am; 1994 Oct; 8(5):961-73. PubMed ID: 7852218
[TBL] [Abstract][Full Text] [Related]
8. [Treatment of anemia in patients with tumors].
Tesarová P; Kvasnicka J
Cas Lek Cesk; 1995 Oct; 134(20):647-50. PubMed ID: 7489579
[TBL] [Abstract][Full Text] [Related]
9. EPO in cancer anemia: benefits and potential risks.
Milano M; Schneider M
Crit Rev Oncol Hematol; 2007 May; 62(2):119-25. PubMed ID: 17197190
[TBL] [Abstract][Full Text] [Related]
10. Impact of anemia and fatigue on quality of life in cancer patients: a brief review.
Thomas ML
Med Oncol; 1998 Aug; 15 Suppl 1():S3-7. PubMed ID: 9785330
[TBL] [Abstract][Full Text] [Related]
11. Anemia therapy: individual benefit and societal cost.
Denton TA; Diamond GA; Matloff JM; Gray RJ
Semin Oncol; 1994 Apr; 21(2 Suppl 3):29-35. PubMed ID: 8202723
[TBL] [Abstract][Full Text] [Related]
12. Treatment of cancer-related anemia.
Badzek S; Curić Z; Krajina Z; Plestina S; Golubić-Cepulić B; Radman I
Coll Antropol; 2008 Jun; 32(2):615-22. PubMed ID: 18756919
[TBL] [Abstract][Full Text] [Related]
13. [Anemia impact on treatments of cervical carcinomas].
Marchal C; Rangeard L; Brunaud C
Cancer Radiother; 2005 Mar; 9(2):87-95. PubMed ID: 15820436
[TBL] [Abstract][Full Text] [Related]
14. The effects of anemia and anemia treatment on the quality of life of people with cancer.
Cella D
Oncology (Williston Park); 2002 Sep; 16(9 Suppl 10):125-32. PubMed ID: 12380962
[TBL] [Abstract][Full Text] [Related]
15. [Tumor anemia. Overview of the role of human recombinant erythropoietin (r-hu-EPO) in treatment of tumor anemia].
Monnerat C; Leyvraz S
Praxis (Bern 1994); 1999 Jan; 88(5):178-88. PubMed ID: 10067375
[TBL] [Abstract][Full Text] [Related]
16. [Updating 1999 of Standards, Options and Recommendations (SOR) for the clinical use of erythropoietin in oncology. FEDERATION OF THE FRENCH CANCER CENTRES (FNCLCC)].
Spaëth D; Marchal C; Bataillard A; Blanc-Vincent MP
Bull Cancer; 1999; 86(7-8):631-9. PubMed ID: 10477381
[TBL] [Abstract][Full Text] [Related]
17. Erythropoietin for anemia of cancer: higher hematocrits, fewer transfusions.
Oncology (Williston Park); 1992 Sep; 6(9):19. PubMed ID: 1449973
[No Abstract] [Full Text] [Related]
18. Cancer-related anemia: clinical review and management update.
Hurter B; Bush NJ
Clin J Oncol Nurs; 2007 Jun; 11(3):349-59. PubMed ID: 17623620
[TBL] [Abstract][Full Text] [Related]
19. Alfa-epoietin and anaemia in gynaecological cancer.
Di Cocco B; Salesi N; Fabi A; Nardoni C; Ferretti G; Bossone G; Ciccarese M; Savarese A; Vecchione A; Cognetti F
Anticancer Res; 2004; 24(2C):1287-92. PubMed ID: 15154662
[TBL] [Abstract][Full Text] [Related]
20. Erythropoietic agents in the management of cancer patients. Part 1: Anemia, quality of life, and possible effects on survival.
Smith RE
J Support Oncol; 2003; 1(4):249-56, 258-9; discussion 257-8. PubMed ID: 15334867
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
